28 Nov 2022 ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP Press Releases BAUDETTE, Minn.–(
28 Nov 2022 Exscientia Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours Press Releases
28 Nov 2022 Lineage Announces Launch of Phase 2a Study by Genentech of RG6501 (OpRegen®) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration Press Releases
28 Nov 2022 Gilead and Arcus Biosciences Announce Positive Update on Joint TIGIT Program From Interim Analysis of ARC-7 Study in Non-Small Cell Lung Cancer Press Releases
28 Nov 2022 Navidea Biopharmaceuticals Announces 50th Participant Enrolled in the Company’s Phase 3 Trial in Rheumatoid Arthritis Press Releases DUBLIN,…
28 Nov 2022 Therapeutic Solutions International Granted Broad Patent on Treatment of Neurodegenerative Conditions Press Releases ELK CITY,…
28 Nov 2022 Medimaps Group Appoints Meinhard F. Schmidt as Board Chairman; Adds Anne Le Grand and Five Additional Board Members Press Releases GENEVA–(…
28 Nov 2022 Ferinject® approved in Chinafor the treatment of iron deficiency in adult patients Press Releases
